• Download Brochure|
  • Careers|
  • CSR|
  • Home
  • About Us
    • Overview
    • Milestones
    • Quality Policy
  • Capabilities
    • Manufacturing Plants
    • Research & Development
  • Product Range
  • MARKETING DIVISIONS
    • Maneesh Healthcare
    • Svizera Healthcare
      • ACE
      • Inspira
    • Svizera Health Remedies
      • Smyle
    • Ergos
  • Contact Us
  • About Us
    • Overview
    • Milestones
    • Quality Policy
  • Capabilities
    • Manufacturing Plants
    • Research & Development
  • Product Range
  • Marketing Divisions
    • Maneesh Healthcare
    • Svizera Healthcare
      • ACE
      • Inspira
    • Svizera Health Remedies
      • Smyle
    • Ergos
  • Contact Us
  • Careers |
    CSR |
    Download Brochure

Milestones

Milestones

2017

2017

MHRA and WHO Geneva Joint Inspection approvals

2017

MHRA and WHO Geneva Joint Inspection approvals

2016

2016

US FDA approval for two plants in India (Maneesh Unit – II and Svizera)

2016

US FDA approval for two plants in India (Maneesh Unit – II and Svizera)

2012

2012

Manufacturing Assets – in India, US, accredited by global agencies like FDA and UK MHRA.

Proven management track record of strategic foresight and smart execution From contract manufacturing to straddling the entire value chain, via organic and inorganic routes in < 10 years

Poised for substantial growth, with key drivers being:

  • Domestic Branded formulation and FMCG offerings
  • Improving fundamentals of overseas assets
  • Group synergies

2012

Manufacturing Assets – in India, US, accredited by global agencies like FDA and UK MHRA.

Proven management track record of strategic foresight and smart execution From contract manufacturing to straddling the entire value chain, via organic and inorganic routes in < 10 years

Poised for substantial growth, with key drivers being:

  • Domestic Branded formulation and FMCG offerings
  • Improving fundamentals of overseas assets
  • Group synergies
2006

2006

International Patents for Anti-TB formulations in a single dose sachet. Built USFDA compliant manufacturing facility at Himachal Pradesh.

2006

International Patents for Anti-TB formulations in a single dose sachet. Built USFDA compliant manufacturing facility at Himachal Pradesh.

2005

2005

Acquisition of ‘Phaarmasia' Hyderabad , a recognized manufacturing facility for Oral – Contraceptives

2005

Acquisition of ‘Phaarmasia' Hyderabad , a recognized manufacturing facility for Oral – Contraceptives

2004

2004

Launch Of 4 Fixed Dose Combination In Sachet

4 million cases cured in 4 years as a sole supplier to WHO GDF

4 FDC product approved by WHO GENEVA for worldwide program. Svizera was only supplier to WHO for first four years.

2004

Launch Of 4 Fixed Dose Combination In Sachet

4 million cases cured in 4 years as a sole supplier to WHO GDF

4 FDC product approved by WHO GENEVA for worldwide program. Svizera was only supplier to WHO for first four years.

2003

2003

First Time In The World Amoxicillin Clavulanate With Lactic Acid Bacillus For The First Time In The World WHO-Geneva Approval

2003

First Time In The World Amoxicillin Clavulanate With Lactic Acid Bacillus For The First Time In The World WHO-Geneva Approval

2002

2002

Started supplying Anti-TB drug in 77 countries WHO- Global Drug Facility

2002

Started supplying Anti-TB drug in 77 countries WHO- Global Drug Facility

2001

2001

4 FDC tab for TB approved by WHO GENEVA for worldwide program. Svizera was only supplier to WHO for first four years.

2001

4 FDC tab for TB approved by WHO GENEVA for worldwide program. Svizera was only supplier to WHO for first four years.

2000

2000

First 3 FDC tab for TB was launched

2000

First 3 FDC tab for TB was launched

1999

1999

Commenced dedicated Anti-TB mfg facility. First 4 FDC tab for TB was successfully developed

1999

Commenced dedicated Anti-TB mfg facility. First 4 FDC tab for TB was successfully developed

1998

1998

Tie up with Medical Export Group, The Netherlands

The same business is now regrouped as Svizera Europe as a Joint Venture with one of founders of MEG

1998

Tie up with Medical Export Group, The Netherlands

The same business is now regrouped as Svizera Europe as a Joint Venture with one of founders of MEG

1994

1994

Exports commenced

1994

Exports commenced

1993

1993

Partnered with H&H to develop and manufacture their derma products

(H&H is now No. 2 derma company in India).

All their products till 2011 were developed and manufactured by Maneesh.

1993

Partnered with H&H to develop and manufacture their derma products

(H&H is now No. 2 derma company in India).

All their products till 2011 were developed and manufactured by Maneesh.

1992

1992

WHO GMP for the first Manufacturing facility in Mumbai

1992

WHO GMP for the first Manufacturing facility in Mumbai

+91 22 6152 6500 / +91 22 6152 6586

info@maneeshpharma.com

Maneesh Pharmaceuticals Ltd., 29-33, Ancillary Industrial Plots, Govandi, Mumbai 400043, India.

Connect With Us:

  • Privacy Policy
  • Terms of use

Ⓒ Maneesh Pharmaceuticals Ltd., 2025

Website Designed & Website Maintenance by Miracleworx Website Designers in Mumbai